Domen CH, Sillau S, Liu Y, Adkins M, et al. Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Delta9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms. Mov Disord 2023 May 22. doi: 10.1002/mds.29447.
PMID: 37212386